Remdesivir COVID-19 Study Evaluation Metrics Changed Last Minute to Make Standard of Care Declaration by NIAID
First, we preface in this writing that it is a good thing that Remdesivir produced positive results. The TrialSite News research team […]
Remdesivir is Not a Knockout Punch against COVID-19 as not Statistically Significant Effect on Mortality
With the latest data coming out of the COVID-19 remdesivir trials, not to mention considerable observational data, leading voices in […]
Are the Coast-Trials in Africa Breaking Ethical Boundaries?
The Coast-trial in Africa, led by Professor Sarah Kiguli in Uganda, was approved in 2016 by the Uganda National Health […]
